Abstract
Exogenous prostaglandin (PGs) have been shown to inhibit dopamine (DA) release from the rabbit retina via an effect on presynaptic EP 3-receptors. In the present study, we investigated the possible involvement of cyclic AMP in DA release and in the prostanoid receptor mediated regulation of DA release from the neural retina. Both forskolin and 8-bromo-cyclic AMP enhanced field stimulation-evoked [ 3H]DA release from isolated, superfused rabbit retinas without affecting basal tracer efflux suggesting that presynaptic cyclic AMP may be involved in the pathway leading to DA release. Forskolin attenuated inhibition of evoked [ 3H]DA release caused by low but not high concentrations of PGE 2. Both PGE 2 and sulprostone had no significant effect on basal cyclic AMP levels but inhibited forskolin-stimulated cyclic AMP formation. Furthermore, sulprostone was more potent than PGE 2 in attenuating forskolin-activated cyclic AMP production. The inhibition of forskolin-elevated cyclic AMP levels caused by PGE 2 was, however, unaffected by the EP 1-receptor antagonist, AH6809. We conclude that the regulation of DA release by presynaptic prostanoid EP 3-receptors may be mediated, at least in part, through an inhibitory effect of adenylyl cyclase.
| Original language | English |
|---|---|
| Pages (from-to) | 73-81 |
| Number of pages | 9 |
| Journal | Journal of Ocular Pharmacology and Therapeutics |
| Volume | 11 |
| Issue number | 1 |
| State | Published - 1995 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Ophthalmology
- Pharmacology (medical)
- Pharmacology, Toxicology and Pharmaceutics(all)
Cite this
Role of cyclic AMP in prostaglandin mediated responses in the neural retina. / Ohia, S. E.; Opere, Catherine A.; Tang, L.; Al-Zadjali, K.
In: Journal of Ocular Pharmacology and Therapeutics, Vol. 11, No. 1, 1995, p. 73-81.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Role of cyclic AMP in prostaglandin mediated responses in the neural retina
AU - Ohia, S. E.
AU - Opere, Catherine A.
AU - Tang, L.
AU - Al-Zadjali, K.
PY - 1995
Y1 - 1995
N2 - Exogenous prostaglandin (PGs) have been shown to inhibit dopamine (DA) release from the rabbit retina via an effect on presynaptic EP 3-receptors. In the present study, we investigated the possible involvement of cyclic AMP in DA release and in the prostanoid receptor mediated regulation of DA release from the neural retina. Both forskolin and 8-bromo-cyclic AMP enhanced field stimulation-evoked [ 3H]DA release from isolated, superfused rabbit retinas without affecting basal tracer efflux suggesting that presynaptic cyclic AMP may be involved in the pathway leading to DA release. Forskolin attenuated inhibition of evoked [ 3H]DA release caused by low but not high concentrations of PGE 2. Both PGE 2 and sulprostone had no significant effect on basal cyclic AMP levels but inhibited forskolin-stimulated cyclic AMP formation. Furthermore, sulprostone was more potent than PGE 2 in attenuating forskolin-activated cyclic AMP production. The inhibition of forskolin-elevated cyclic AMP levels caused by PGE 2 was, however, unaffected by the EP 1-receptor antagonist, AH6809. We conclude that the regulation of DA release by presynaptic prostanoid EP 3-receptors may be mediated, at least in part, through an inhibitory effect of adenylyl cyclase.
AB - Exogenous prostaglandin (PGs) have been shown to inhibit dopamine (DA) release from the rabbit retina via an effect on presynaptic EP 3-receptors. In the present study, we investigated the possible involvement of cyclic AMP in DA release and in the prostanoid receptor mediated regulation of DA release from the neural retina. Both forskolin and 8-bromo-cyclic AMP enhanced field stimulation-evoked [ 3H]DA release from isolated, superfused rabbit retinas without affecting basal tracer efflux suggesting that presynaptic cyclic AMP may be involved in the pathway leading to DA release. Forskolin attenuated inhibition of evoked [ 3H]DA release caused by low but not high concentrations of PGE 2. Both PGE 2 and sulprostone had no significant effect on basal cyclic AMP levels but inhibited forskolin-stimulated cyclic AMP formation. Furthermore, sulprostone was more potent than PGE 2 in attenuating forskolin-activated cyclic AMP production. The inhibition of forskolin-elevated cyclic AMP levels caused by PGE 2 was, however, unaffected by the EP 1-receptor antagonist, AH6809. We conclude that the regulation of DA release by presynaptic prostanoid EP 3-receptors may be mediated, at least in part, through an inhibitory effect of adenylyl cyclase.
UR - http://www.scopus.com/inward/record.url?scp=0028999298&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028999298&partnerID=8YFLogxK
M3 - Article
C2 - 8535960
AN - SCOPUS:0028999298
VL - 11
SP - 73
EP - 81
JO - Journal of Ocular Pharmacology and Therapeutics
JF - Journal of Ocular Pharmacology and Therapeutics
SN - 1080-7683
IS - 1
ER -